Market Overview

Benzinga's Top #PreMarket Gainers


Celladon Corporation (NASDAQ: CLDN) shares gained 11.45% to $21.90 in the pre-market trading session. Roth Capital initiated coverage on Celladon with a Buy rating.

Roundy's, Inc. (NYSE: RNDY) shares rose 10.95% to $4.46 in pre-market trading after the company reported stronger-than-expected results for the fourth quarter.

Pharmacyclics Inc. (NASDAQ: PCYC) shares surged 9.87% to $253.22 in pre-market trading after AbbVie (NYSE: ABBV) announced its plans to acquire Pharmacyclics for $261.25 per share in cash and stock.

Navidea Biopharmaceuticals, Inc (NYSE: NAVB) shares climbed 9.82% to $1.79 in pre-market trading on Q4 results. Navidea Biopharmaceuticals reported a Q3 loss of $0.08 per share on revenue of $2.2 million.

Arrowhead Research Corp. (NASDAQ: ARWR) gained 9.19% to $8.20 in pre-market trading after the company reported the acquisition of Novartis' entire RNAi research and development portfolio and associated assets.


Related Articles (RNDY + CLDN)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at